Paeds SAQs · genetics-dysmorphology-and-metabolism
Dysmorphology examination and syndrome recognition — formative SAQs
Formative SAQs on a structured dysmorphology examination, anomaly classification, syndrome differential generation and tiered genetic testing.
On this page & tools
Target exams
SAQ 1 (10 marks)
A term newborn is referred for a detailed assessment after the midwife notes an unusual face and a heart murmur. [1]
- Outline your structured dysmorphology examination and documentation. (4) [1] [3]
- Define a major versus a minor anomaly, and explain the significance of finding three or more minor anomalies. (3) [3] [5]
- State your first-tier genetic investigation and your next step if it is negative. (3) [7] [9] [10]
Model answer
Observe the undressed, settled child first, then examine systematically head to toe — skull and face, neck and chest, abdomen and genitalia, spine, limbs, skin and neurology — describing each finding in standard Elements of morphology terms and avoiding vague language. [1] [3] Measure occipitofrontal circumference and the facial distances against norms, take standardised photographs with consent, and examine the parents. [1] A major anomaly has a structural, medical or surgical consequence; a minor anomaly does not on its own; three or more minor anomalies meaningfully raises the probability of an underlying syndrome and demands a search. [3] [5] First-tier testing is chromosomal microarray; if it is negative and a monogenic syndrome is likely, escalate to exome or genome sequencing, while organising the organ-targeted work-up (for example echocardiography) the pattern demands. [7] [9] [10]
SAQ 2 (10 marks)
Compare the Elements of morphology mechanism categories and outline how they change counselling. [3]
- Define malformation, disruption, deformation and dysplasia with one example of each. (6) [3]
- Explain how mechanism and timing alter prognosis, recurrence-risk discussion and what else you examine for. (4) [3] [5]
Model answer
A malformation is intrinsic poor tissue formation during organogenesis (e.g. cleft palate, congenital heart defect); a disruption is extrinsic destruction of normally formed tissue (e.g. amniotic-band limb defect); a deformation is mechanical moulding of normal tissue, often late and often reversible (e.g. positional clubfoot from oligohydramnios); a dysplasia is abnormal organisation of cells in a tissue (e.g. achondroplasia). [3] Mechanism and timing matter because a deformation may resolve once the cause is removed (better prognosis, lower recurrence risk), whereas a malformation is fixed and a dysplasia may progress; a disruption or deformation in one region should still prompt a search for malformations elsewhere, and the recurrence-risk discussion differs for a multifactorial malformation versus a monogenic cause. [3] [5]
References
- [1]Allanson JE, Biesecker LG, Carey JC, Hennekam RC Elements of morphology: introduction. American Journal of Medical Genetics Part A, 2009.PMID 19127575
- [3]Hennekam RC, Biesecker LG, Allanson JE, Hall JG, Opitz JM, Temple IK Elements of morphology: general terms for congenital anomalies. American Journal of Medical Genetics Part A, 2013.PMID 24124000
- [5]Carey JC, Allanson JE, Hennekam RC, Biesecker LG Standard terminology for phenotypic variations: the elements of morphology project, its current progress, and future directions. Human Mutation, 2012.PMID 22331827
- [7]Moeschler JB, Shevell M, American Academy of Pediatrics Committee on Genetics Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics, 2006.PMID 16740881
- [9]Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 2010.PMID 20466091
- [10]Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 2021.PMID 34211152